Eva Prescott

Education 1990 MD, University of Copenhagen, 2000 DMSc, University of Copenhagen. Specialized in Internal Medicine and Cardiology Appointments 2007 Chief physician dept Cardiology, Bispebjerg University Hospital 2009 Professor of Cardiology, University of Copenhagen Research profile and leadership experience My main research interests are: Prevention of coronary artery disease (CAD) with a focus on risk factors including socioeconomic and psychosocial precursors, risk prediction models, diagnostics and management of stable CAD and coronary microvascular dysfunction. I have addressed these topics through population and registry studies, clinical studies and several randomized trials. International collaboration and positions of trust Participation and steering committee member of several international investigator-initiated trials, including the SMARTEX-HF trial and the Horizon2020 EU-CaRE study. I am part of the Coronary Vasomotor Disorders International Study Group (COVADIS), the steering committee for the Copenhagen City Heart Study and the Advisory Board for the Swedish SCAPIS study. Through my work in the ESC over more than 10 years, including in development of clinical guidelines I have developed a strong international network. Leadership and grants Supervision of 25 completed and 7 ongoing phd studies and 23 completed master graduates. Reviewer of 31 national and international PhD theses, 5 doctoral theses and 7 professorships. Total funding >13 mio EU, including Horizon2020 (co-PI, 6 mio EU). PI of the following ongoing or concluded clinical trials: MAINTAIN, RCT of exercise training in Chronic Heart Failure HOME-BASE, RCT of centre based training with home-based training in elderly patients with CHD HTX, RCT of high intensity interval exercise training in heart transplant recipients SMARTEX-HF, International RCT of interval training, in chronic Heart Failure. CUT-IT, RCT of intensive training vs intensive diet in obese patients with CHD iPOWER, National multicentre study of microvascular disease in women. Includes several RCTs (ACE-inhibition, GLP1RA, SGLT2i, comprehensive risk factor control) EU-CaRE, Horizon 2020 study of cardiac rehabilitation in 8 European Countries and a RCT of tele-rehabilitation in the elderly. DANBLOCK, PI of this national Danish trial of betablocker treatment after myocardial. 3750 patients will be randomized over 2 years. Funded by the Danish Heart Foundation and NovoNordiskFonden FILTERSCAD, Multicenter RCT of the cost-effectiveness and safety of adding the CADScor®System as a rule-out test in patients with suspected stable CAD Academic awards and honours -selected Grosserer Johan Quentin og Hustru’s forskningshæderspris 2006, The Danish Society of Cardiology Scientific Research Award 2011, member of the Danish Council for Independent Research 2016-2022, Speaker at the Highlights session at ESC congress 2017-2019 (approx. 35000 attendees). Impact award and Senior researcher of the year 2020, Bispebjerg University Hospital Other scientific qualifications - selected Multiple leadership and roles of trust under the ESC, including chair Prevention, Epidemiology and Population Science under EAPCR (2014-16). Co-writer of the guidelines on prevention 2011&15, stable CAD 2014&19, STEMI 2017, and Sportscardiology and exercise 2020. Member of the editorial board for the European Heart Journal (IF 24) (2018-), the ethical committee for the ESC (2019-), the oversight committee for the EURObservational research program (2020-22) and current chair of the ESC Committee for Practice Guidelines 2022-24. Extensive experience as research reviewer, including in Danish, Swedish and Norwegian research councils, Caixa Foundation, KGJebsen Foundation and the UK MRC.